ClinConnect ClinConnect Logo
Search / Trial NCT03016182

Remote Ischemic Preconditioning on Pulmonary Injury in Cardic Surgery

Launched by XUZHOU MEDICAL UNIVERSITY · Jan 7, 2017

Trial Information

Current as of June 04, 2025

Unknown status

Keywords

ClinConnect Summary

Remote ischemic preconditioning (RIPC) protocol will be induced during anesthesia by 3 cycles of 5-min upper limb ischemia and 5-min reperfusion using a blood pressure cuff inflated to a pressure 200mmHg

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients undergoing heart surgery on cardiopulmonary bypass
  • 2. Patients aged 18 years to 80 years
  • Exclusion Criteria:
  • 1. Inability to give informed consent
  • 2. Preoperative severe impairment of respiratory function (arterial oxygen tension (PaO2) \<60 mmHg or FEV1\<50% predicted)
  • 3. Prior receipt of chemotherapy or radiation therapy or immunotherapy
  • 4. left ventricular ejection fraction less than 30%
  • 5. preoperative use of inotropics or mechanical assist device
  • 6. Patients with significant hepatic dysfunction (Prothrombin\>2.0 ratio)
  • 7. Patients with known renal failure with a GFR\<30 mL/min/1.73 m2
  • 8. recent myocardial infarction (within 7 days)
  • 9. Systemic or local active infections (either clinically defined or suggested by evidence such as elevated C-reactive protein levels, leukocytosis, or a body temperature\>38℃)
  • 10. Significant peripheral arterial disease affecting the upper limbs
  • 11. surgeries: cardiac transplantation, concomitant carotid endarterectomy , previous heart surgery,, off-pump surgery, emergency surgery

About Xuzhou Medical University

Xuzhou Medical University is a leading institution in medical education and research, dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university conducts a range of studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. Leveraging its state-of-the-art facilities and a team of experienced researchers and clinicians, Xuzhou Medical University fosters collaboration across disciplines to address critical health challenges, ensuring the highest level of care and safety for trial participants.

Locations

Xuzhou, Jiangsu, China

Patients applied

0 patients applied

Trial Officials

Liu Su, M.D/Ph.D

Principal Investigator

The Affiliated Hospital of Xuzhou Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials